Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-22

FDA Approved: VELTASSA — Supplemental Application (Vifor Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VELTASSA (patiromer) from Vifor Pharma, Inc., resulting in an updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Veltassa (patiromer)

Snippet

SUPPL AP for VELTASSA (PATIROMER)